{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "3326874",
  "DateCompleted": {
    "Year": "1988",
    "Month": "04",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0305-7453",
      "JournalIssue": {
        "Volume": "20",
        "Issue": "6",
        "PubDate": {
          "Year": "1987",
          "Month": "Dec"
        }
      },
      "Title": "The Journal of antimicrobial chemotherapy",
      "ISOAbbreviation": "J Antimicrob Chemother"
    },
    "ArticleTitle": "Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteers.",
    "Pagination": {
      "StartPage": "887",
      "EndPage": "892",
      "MedlinePgn": "887-92"
    },
    "Abstract": {
      "AbstractText": [
        "The antirhinovirus agent chalcone Ro 09-0410 was tested in double-blind place-controlled volunteer trials for its protective efficacy against experimental rhinovirus infection. Fifty volunteers received either drug (26 volunteers) or placebo (24 volunteers) both before and after challenge with 20-40 tissue culture infecting dose (TCID50) of human rhinovirus 2 (RV2). There was no evidence that medication significantly reduced the incidence of infection or illness, indeed there was some increase in the nasal secretion produced."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "MRC Common Cold Unit, Harvard Hospital, Salisbury, Wiltshire, U.K."
          }
        ],
        "LastName": "Al-Nakib",
        "ForeName": "W",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Higgins",
        "ForeName": "P G",
        "Initials": "PG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Barrow",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tyrrell",
        "ForeName": "D A",
        "Initials": "DA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lenox-Smith",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ishitsuka",
        "ForeName": "H",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Controlled Clinical Trial",
      "Journal Article",
      "Randomized Controlled Trial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Antimicrob Chemother",
    "NlmUniqueID": "7513617",
    "ISSNLinking": "0305-7453"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Chalcones"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Propiophenones"
    },
    {
      "RegistryNumber": "5S5A2Q39HX",
      "NameOfSubstance": "Chalcone"
    },
    {
      "RegistryNumber": "76554-66-0",
      "NameOfSubstance": "Ro 09-0410"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Intranasal"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "analogs & derivatives"
      ],
      "DescriptorName": "Chalcone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Chalcones"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Propiophenones"
    }
  ]
}